We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Luminex Corporation Begins Clinical Trials for ARIES™ GBS Assay

News   Jun 09, 2015

 
Luminex Corporation Begins Clinical Trials for ARIES™ GBS Assay
 
 
Advertisement
 

RELATED ARTICLES

Data Shows Pfizer-BioNTech COVID-19 Vaccine Provides Protection From First Dose

News

An independent analysis conducted by Public Health England (PHE) in the UK demonstrates that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 provides protection against infection and asymptomatic disease after the first dose.

READ MORE

Scientists Repair Injured Spinal Cord Using Patients’ Own Stem Cells

News

Intravenous injection of bone marrow derived stem cells (MSCs) in patients with spinal cord injuries led to significant improvement in motor functions, researchers from Yale University and Japan report in the Journal of Clinical Neurology and Neurosurgery.

READ MORE

First-of-Its-Kind Coronavirus Human Challenge Study Approved in UK

News

Backed by a £33.6 million UK government investment, the first-of-its-kind study for this virus will involve establishing the smallest amount of virus needed to cause infection, which will give doctors greater understanding of COVID-19 and help support the pandemic response by aiding vaccine and treatment development.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE